UroToday

Feasibility and radiation induced toxicity regarding the first application of transperineal implementation of biocompatible balloon for high dose radiotherapy in patients with prostate carcinoma - Abstract

Published on Tuesday, 21 May 2013 06:19

OBJECTIVE: To evaluate the feasibility of the transperineal implementation of biocompatible balloon (Prospace) and the acute toxicity of high dose 3DCRT in patients with localized low risk prostate cancer.

Dietary supplements and prostate cancer: A systematic review of double-blind, placebo-controlled randomised clinical trials - Abstract

Published on Tuesday, 21 May 2013 06:09

Dietary supplements are popular among patients with prostate cancer (PC).

Statin use and risk of prostate cancer and high-grade prostate cancer: Results from the REDUCE study - Abstract

Published on Tuesday, 21 May 2013 05:56

Background: Statins are associated with lower PSA levels.

Comparison of three versions of Partin tables to predict final pathologic stage in a Chinese cohort: A decision curve analysis - Abstract

Published on Monday, 20 May 2013 21:08

Purpose: To compare Partin tables (PTs) 1997, 2001, and 2007 for their clinical applicability in a Chinese cohort based upon a decision curve analysis (DCA).

Diffusion pattern of low dose rate brachytherapy for prostate cancer in Japan - Abstract

Published on Monday, 20 May 2013 21:03

Permanent implant brachytherapy for prostate cancer using iodine-125 seeds was adopted in Japan in 2003.

The interval to biochemical failure is prognostic for metastasis, prostate cancer-specific mortality, and overall mortality after salvage radiation therapy for prostate cancer - Abstract

Published on Monday, 20 May 2013 20:59

PURPOSE: To investigate the utility of the interval to biochemical failure (IBF) after salvage radiation therapy (SRT) after radical prostatectomy (RP) for prostate cancer as a surrogate endpoint for distant metastasis (DM), prostate cancer-specific mortality (PCSM), and overall mortality (OM).

Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: The PROSTQA experience - Abstract

Published on Monday, 20 May 2013 20:52

PURPOSE: To evaluate patients treated with external beam radiation therapy as part of the multicenter Prostate Cancer Outcomes and Satisfaction with Treatment Quality Assessment (PROSTQA), to identify factors associated with posttreatment patient-reported bowel health-related quality of life (HRQOL).

The fat side of prostate cancer - Abstract

Published on Monday, 20 May 2013 20:45

Prostate cancer (PCa) metabolism appears to be unique in comparison with other types of solid cancers.

Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D - Abstract

Published on Monday, 20 May 2013 20:41

Androgen deprivation therapy in 80 men was associated with declines in bone mineral density (BMD), which were greatest in the first year, and in the lumbar spine compared to controls.

Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer - Abstract

Published on Monday, 20 May 2013 20:36

PURPOSE: Recurrent prostate cancer is usually treated by combining radiotherapy and androgen deprivation therapy.

Page 3 of 1750